Sustained virologic response in treatment-experienced patients with HCV genotype 1 is increased by simeprevir

被引：0
|
作者：
机构：
来源：
Nature Reviews Gastroenterology & Hepatology | 2014年 / 11卷 / 1期
关键词：
D O I：
10.1038/nrgastro.2013.249
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [1] Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
    Zeuzem, Stefan
    Berg, Thomas
    Gane, Edward
    Ferenci, Peter
    Foster, Graham R.
    Fried, Michael W.
    Hezode, Christophe
    Hirschfield, Gideon M.
    Jacobson, Ira
    Nikitin, Igor
    Pockros, Paul J.
    Poordad, Fred
    Scott, Jane
    Lenz, Oliver
    Peeters, Monika
    Sekar, Vanitha
    De Smedt, Goedele
    Sinha, Rekha
    Beumont-Mauviel, Maria
    GASTROENTEROLOGY, 2014, 146 (02) : 430 - +
  • [2] ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
    Andreone, Pietro
    Colombo, Massimo G.
    Enejosa, Jeffrey V.
    Koksal, Iftihar
    Ferenci, Peter
    Maieron, Andreas
    Muellhaupt, Beat
    Horsmans, Yves
    Weiland, Ola
    Reesink, Henk W.
    Rodrigues, Lino, Jr.
    Hu, Yiran B.
    Podsadecki, Thomas
    Bernstein, Barry
    GASTROENTEROLOGY, 2014, 147 (02) : 359 - +
  • [3] Resistance Analysis of Treatment-Experienced HCV Genotype 1 Infected Patients Retreated with Sofosbuvir
    Mo, Hongmei
    Doehle, Brian
    Gontcharova, Viktoria
    Chodavarapu, Ramakrishna K.
    Kanwar, Bittoo
    Jacobson, Ira M.
    Pol, Stanislas
    Brainard, Diana M.
    McHutchison, John G.
    Miller, Michael D.
    HEPATOLOGY, 2014, 60 : 664A - 664A
  • [4] Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
    Hezode, Christophe
    Fontaine, Helene
    Dorival, Celine
    Zoulim, Fabien
    Larrey, Dominique
    Canva, Valerie
    De Ledinghen, Victor
    Poynard, Thierry
    Samuel, Didier
    Bourliere, Marc
    Alric, Laurent
    Raabe, Jean-Jacques
    Zarski, Jean-Pierre
    Marcellin, Patrick
    Riachi, Ghassan
    Bernard, Pierre-Henri
    Loustaud-Ratti, Veronique
    Chazouilleres, Olivier
    Abergel, Armand
    Guyader, Dominique
    Metivier, Sophie
    Tran, Albert
    Di Martino, Vincent
    Causse, Xavier
    Dao, Thong
    Lucidarme, Damien
    Portal, Isabelle
    Cacoub, Patrice
    Gournay, Jerome
    Grando-Lemaire, Veronique
    Hillon, Patrick
    Attali, Pierre
    Fontanges, Thierry
    Rosa, Isabelle
    Petrov-Sanchez, Ventzislava
    Barthe, Yoann
    Pawlotsky, Jean-Michel
    Pol, Stanislas
    Carrat, Fabrice
    Bronowicki, Jean-Pierre
    GASTROENTEROLOGY, 2014, 147 (01) : 132 - U235
  • [5] Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2
    Sikuler, Emanuel
    Tur-Kaspa, Ran
    Shemer-Avni, Yonat
    Delgado, Jorge
    Zilberman, Doron
    Fich, Alexander
    Baruch, Yaacov
    Hyam, Eytan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (06) : 730 - 733
  • [6] A Real Life Boceprevir Use in Treatment-Experienced HCV Genotype 1 Patients with Advanced Fibrosis
    Gheorghe, Liana
    Iacob, Speranta
    Simionov, Iulia
    Caruntu, Florin
    Motoc, Adriana
    Arama, Victoria
    Preotescu, Liliana
    Stefan, Ion
    Goldis, Adrian
    Brisc, Cristian
    Rugina, Sorin
    Rednic, Nicolae
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (01) : 45 - 50
  • [7] Correlates of a sustained virologic response in the treatment of HCV
    Hoqfs, John C.
    Herron, Tom
    Lizotte, Paul E.
    Chen, Wen-Pin
    McLaren, Christine E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S160 - S161
  • [8] THE EFFECT OF SUSTAINED VIROLOGIC RESPONSE ON CEREBRAL METABOLISM AND NEUROCOGNITION IN PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
    Curry, M. P.
    Moczynski, N. P.
    Liu, L.
    Stamm, L.
    Yun, C.
    Brainard, D. M.
    McHutchison, J. G.
    Alsop, D.
    Afdhal, N. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S797 - S797
  • [9] SUSTAINED VIRAL RESPONSE AND SAFETY OF MK-7009 IN CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT
    Rodriguez-Torres, M.
    Stoehr, A.
    Gane, E.
    Serfaty, L.
    Lawitz, E.
    Bourque, M.
    Bhanja, S.
    Barnard, R.
    Hwang, P.
    Mobashery, N.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S47 - S47
  • [10] Sustained virologic response by ledipasvir/sofosbuvir reduces the incidence of hepatocellular carcinoma in Japanese patients with HCV genotype 1 infection. - Comparison with Simeprevir with peginterferon plus ribavirin
    Korenaga, M.
    Izumi, N.
    Yokosuka, O.
    Takehara, T.
    Sakamoto, N.
    Nishiguchi, S.
    Ikeda, F.
    Yanase, M.
    Toyota, H.
    Genda, T.
    Umemura, T.
    Yatsuhashi, H.
    Ide, T.
    Toda, N.
    Nirei, K.
    Ueno, Y.
    Nishigaki, Y.
    Omata, M.
    Mizokami, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S23 - S23
12345